Xylocaine 1% with adrenaline (epinephrine) 1:100,000 ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 1% with adrenaline (epinephrine) 1:100,000 ampoule

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections; sodium hydroxide; sodium metabisulfite - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Xylocaine 1% with adrenaline (epinephrine) 1:200,000 20mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 1% with adrenaline (epinephrine) 1:200,000 20ml injection vial

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium metabisulfite; sodium hydroxide; sodium chloride - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Xylocaine 1% (20mg/2mL) ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 1% (20mg/2ml) ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Xylocaine 0.5% with adrenaline (epinephrine) 1:200,000 20mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 0.5% with adrenaline (epinephrine) 1:200,000 20ml injection vial

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 5 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

XYLOCAINE SPECIAL ADHESIVE lidocaine (lignocaine) 100mg/g ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine special adhesive lidocaine (lignocaine) 100mg/g ointment tube

aspen pharmacare australia pty ltd - lidocaine, quantity: 100 mg/g - ointment - excipient ingredients: macrogol 400; macrogol 1500; propylene glycol; macrogol 300; spearmint oil; carmellose sodium - surface anaesthesia of the gums prior to injection, before scaling and in conjunction with the fitting of new dentures or orthodontic appliances. temporary relief of pain associated with removal of deciduous teeth.

XYLOCAINE 2.0% WITH ADRENALINE 1:80,000 5mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 2.0% with adrenaline 1:80,000 5ml injection ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty microgram/ml) - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Xylocaine 1.5% with adrenaline (epinephrine) 1:200,000 20mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 1.5% with adrenaline (epinephrine) 1:200,000 20ml injection vial

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 15 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Xylocaine 0.5% (25mg/5mL) ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 0.5% (25mg/5ml) ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Xylocaine 2% (44mg/2.2mL) injection cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 2% (44mg/2.2ml) injection cartridge

dentsply sirona pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of inflitration and nerve block techniques.